68.57
price up icon5.80%   3.76
after-market 시간 외 거래: 71.99 3.42 +4.99%
loading
전일 마감가:
$64.81
열려 있는:
$64.98
하루 거래량:
1.82M
Relative Volume:
0.97
시가총액:
$11.78B
수익:
$342.96M
순이익/손실:
$-864.29M
주가수익비율:
-12.35
EPS:
-5.55
순현금흐름:
$-636.03M
1주 성능:
-0.88%
1개월 성능:
-6.96%
6개월 성능:
-8.03%
1년 성능:
+140.09%
1일 변동 폭
Value
$64.34
$68.63
1주일 범위
Value
$60.40
$70.52
52주 변동 폭
Value
$21.92
$84.91

Insmed Inc Stock (INSM) Company Profile

Name
명칭
Insmed Inc
Name
전화
908-977-9900
Name
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
직원
1,271
Name
트위터
@insmed
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
INSM's Discussions on Twitter

INSM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
INSM
Insmed Inc
68.57 11.78B 342.96M -864.29M -636.03M -5.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.22 122.24B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.18 59.73B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
580.94 35.43B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
237.77 30.77B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
96.52 23.20B 3.30B -501.07M 1.03B -2.1146

Insmed Inc Stock (INSM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-25 개시 RBC Capital Mkts Outperform
2024-04-23 개시 Truist Buy
2024-02-15 개시 Wolfe Research Outperform
2023-12-08 개시 Wells Fargo Overweight
2023-11-20 재개 JP Morgan Overweight
2023-07-26 개시 Guggenheim Buy
2022-12-09 개시 Mizuho Buy
2022-12-07 개시 Barclays Overweight
2022-11-18 개시 BofA Securities Buy
2022-04-27 개시 Goldman Buy
2021-12-06 개시 JP Morgan Overweight
2021-10-19 재개 Monness Crespi & Hardt Buy
2021-10-19 재개 Morgan Stanley Overweight
2021-10-08 개시 Cantor Fitzgerald Overweight
2021-04-26 재개 Credit Suisse Outperform
2020-12-17 개시 Berenberg Buy
2020-10-12 재개 Stifel Buy
2019-09-03 개시 Goldman Buy
2019-04-09 재확인 H.C. Wainwright Buy
2019-02-15 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 업그레이드 Goldman Neutral → Buy
2019-01-02 개시 Canaccord Genuity Buy
2018-08-06 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 개시 Goldman Neutral
2018-04-23 업그레이드 Credit Suisse Neutral → Outperform
2018-03-21 개시 Morgan Stanley Overweight
2018-01-18 개시 Credit Suisse Neutral
2017-09-05 재확인 Evercore ISI Outperform
2017-08-17 개시 Evercore ISI Outperform
2017-07-11 개시 Robert W. Baird Outperform
2016-03-15 개시 Stifel Buy
2015-11-09 다운그레이드 UBS Buy → Neutral
2015-10-06 재확인 H.C. Wainwright Buy
2015-06-09 개시 Citigroup Neutral
2014-03-26 재확인 HC Wainwright Buy
모두보기

Insmed Inc 주식(INSM)의 최신 뉴스

pulisher
Apr 11, 2025

Commit To Purchase Insmed At $50, Earn 13.9% Annualized Using Options - Nasdaq

Apr 11, 2025
pulisher
Apr 11, 2025

Cantor Fitzgerald maintains Overweight on Insmed stock, bullish on TPIP By Investing.com - Investing.com Canada

Apr 11, 2025
pulisher
Apr 08, 2025

Is Insmed Incorporated (INSM) the Best Long Term Growth Stock to Buy According to Billionaires? - Yahoo Finance

Apr 08, 2025
pulisher
Apr 04, 2025

Form DEF 14A INSMED Inc For: May 15 - StreetInsider

Apr 04, 2025
pulisher
Apr 03, 2025

Insmed CEO William Lewis sells $502,577 in stock - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Insmed CEO William Lewis sells $502,577 in stock By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 02, 2025

Insmed Incorporated (INSM): Insiders Were Dumping in Q1 2025 - Insider Monkey

Apr 02, 2025
pulisher
Mar 25, 2025

Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Breakthrough Data: Insmed's Phase 3 Trial Could Transform Bronchiectasis Treatment - Stock Titan

Mar 25, 2025
pulisher
Mar 22, 2025

Insmed’s SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada

Mar 22, 2025
pulisher
Mar 22, 2025

Insmed’s SWOT analysis: rare disease biotech stock poised for growth - Investing.com

Mar 22, 2025
pulisher
Mar 20, 2025

Insmed reports preclinical data on INS-1201 for DMD - BioWorld MedTech

Mar 20, 2025
pulisher
Mar 19, 2025

Insmed CEO William Lewis sells $1.97 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Insmed’s stock should triple after positive drug trial data, analyst says - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

H.C. Wainwright maintains Buy on Insmed stock, $90 target By Investing.com - Investing.com Canada

Mar 19, 2025
pulisher
Mar 19, 2025

Insmed CEO William Lewis sells $1.97 million in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Expert Outlook: Insmed Through The Eyes Of 13 Analysts - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

RBC maintains Outperform on Insmed stock, price target at $100 By Investing.com - Investing.com Canada

Mar 19, 2025
pulisher
Mar 18, 2025

Insmed Incorporated (INSM): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Mar 18, 2025
pulisher
Mar 15, 2025

15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 15, 2025
pulisher
Mar 12, 2025

Truist maintains Buy on Insmed stock, sees PAH data as positive - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

US Bancorp DE Boosts Holdings in Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Truist maintains Buy on Insmed stock, sees PAH data as positive By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Insmed at Leerink Global Healthcare Conference: Optimism for Brenzo’s Launch By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Insider Sell: Roger Adsett Sells 42,975 Shares of Insmed Inc (IN - GuruFocus.com

Mar 11, 2025
pulisher
Mar 11, 2025

Insmed at Leerink Global Healthcare Conference: Optimism for Brenzo’s Launch - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Smartleaf Asset Management LLC - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Citizentribune

Mar 10, 2025
pulisher
Mar 10, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) -March 10, 2025 at 08:01 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Insmed Expands Team with Stock Options Grant to 18 New Hires - StockTitan

Mar 10, 2025
pulisher
Mar 08, 2025

UBS Group Raises Insmed (NASDAQ:INSM) Price Target to $110.00 - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Insmed’s Strategic Growth and Promising Pipeline Drive Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

UBS raises Insmed stock price target to $110 By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 06, 2025

Insmed CEO Lewis sells $1.99 million in stock By Investing.com - Investing.com Australia

Mar 06, 2025
pulisher
Mar 05, 2025

Insmed CEO Lewis sells $1.99 million in stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Amalgamated Bank Boosts Stake in Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Sanctuary Advisors LLC Acquires 464 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

Mar 05, 2025
pulisher
Mar 01, 2025

Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024 - Star Tribune

Mar 01, 2025
pulisher
Mar 01, 2025

RBC Capital starts Insmed at Outperform on brensocatib launch momentum - MSN

Mar 01, 2025
pulisher
Mar 01, 2025

Guggenheim Reaffirms Buy Rating for Insmed (NASDAQ:INSM) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Investor Network: Insmed Incorporated to Host Earnings Call - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Major Public Health Interest? Scholar, Insmed & Soleno Ask EMA To Fast-Track Their Products - insights.citeline.com

Feb 27, 2025
pulisher
Feb 27, 2025

Truist Financial Corp Boosts Stake in Insmed Incorporated (NASDAQ:INSM) - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Insmed (NASDAQ:INSM) Now Covered by Royal Bank of Canada - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

RBC Capital Initiates Coverage of Insmed (LSE:0JAV) with Outperform Recommendation - Nasdaq

Feb 26, 2025

Insmed Inc (INSM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Insmed Inc 주식 (INSM) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Lewis William
Chair and CEO
Apr 01 '25
Sale
73.58
6,830
502,577
233,924
$18.81
price up icon 4.44%
$31.95
price up icon 2.37%
$23.24
price up icon 15.33%
biotechnology ONC
$230.36
price up icon 10.59%
$96.52
price up icon 3.65%
자본화:     |  볼륨(24시간):